Vyant Bio Inc (VYNT) Return on Assets ROA from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vyant Bio Inc   (NASDAQ: VYNT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Vyant Bio Inc 's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Vyant Bio Inc 's ROA in the fourth quarter of 2022?
Vyant Bio Inc recorded a cumulative net loss of $-23 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on assets (ROA) of -94.42%.

However, within the Healthcare sector 1074 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from 5415 to 5915.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Total Assets Change -61.17 % -62.37 % -60.3 % -55.08 % 462.07 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -23 -43 -44 -43 -41
Return On Assets (TTM) -94.42 % -145.3 % -112.57 % -86.72 % -69.07 %
VYNT's Total Ranking # 5915 # 5415 # 5434 # 5266 # 5512
Total Assets (TTM) in million 15 23 26 33 38
Seq. Total Assets Change -36.56 % -11.27 % -20.1 % -13.65 % -38.52 %
Seq. Net Income Change - - - - -

VYNT's 5 Years Annual ROA >> Back to VYNT Management Effectiveness >> Compare VYNT ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 54
Sector # 1075
Overall # 5724

Return On Assets Statistics
High Average Low
-12.88 %
-51.39 %
-144.24 %
(Jun 30 2020)   (Sep 30 2022)





Financial Statements
Vyant Bio Inc 's Assets $ 15 million VYNT's Balance sheet
Vyant Bio Inc 's Income $ -4 million Quarterly VYNT's Income Statement
VYNT's Income by Division See VYNT's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -61.17 % 350.84 % -42.62 % -58.91 % -32.2 %
Total Assets in million 15 38 8 15 35
Y / Y Net Income Change - - - - -
Net Income in million -23 -41 -8 -7 -20
Annual Return On Assets -155.25 % -108.56 % -95.84 % -46.11 % -57.54 %

VYNT's 5 Years Annual ROA >> Back to VYNT Management Effectiveness >> Compare VYNT ROA to its Competitors



More Return On Assets Ratios
VYNT's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VYNT's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VYNT's Competitors
Subscribers only: Roa for Vyant Bio Inc 's Suppliers
Subscribers only: Return On Assets for VYNT's Customers

You may also want to know
VYNT's Roi VYNT's Inventory Turnover Ratio VYNT's Growth Rates VYNT's Dividend Comparisons
VYNT's Profitability Ratios VYNT's Asset Turnover Ratio VYNT's Dividend Growth
VYNT's Roe VYNT's Valuation Ratios VYNT's Financial Strength Ratios VYNT's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:54+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.